Lung Cancer Screening Predicts Risk of Death from Heart Disease
Low-dose CT offers an opportunity to screen for cardiovascular disease and calcium buildup
A deep learning (DL) algorithm accurately predicts the risk of death from cardiovascular disease using information from low-dose CT exams performed for lung cancer screening, according to a study in Radiology: Cardiothoracic Imaging.
Low-dose CT lung scans are used to screen for lung cancer in high-risk people such as heavy smokers. These CT scans also provide an opportunity to screen for cardiovascular disease by extracting information about calcification in the heart and aorta. The presence of calcium in these areas is linked with the buildup of plaque and is a strong predictor for cardiovascular disease mortality, heart attacks and strokes.
Previous studies have used information extracted from CT images as well as other risk factors, such as cholesterol levels and blood pressure, and self-reported clinical data, such as history of illness.
For the new study, researchers tested a faster, automated method that can predict five-year cardiovascular disease mortality with only minimal extra workload. The method draws upon the power of DL.
Deep Learning Method Can Be An Added Benefit to Lung Screening
Using data from 4,451 participants, median age 61 years, who underwent low-dose CT over a two-year period in the National Lung Screening Trial, the researchers trained the method to quantify six types of vascular calcification. They then tested the method on data from 1,113 participants.
The prediction model using calcium scores outperformed the baseline model that used only self-reported participant characteristics, such as age, history of smoking, and history of illness.
The method works in two stages, according to study lead author Bob D. de Vos, PhD, from Amsterdam University Medical Center in Amsterdam and the Image Sciences Institute, University Medical Center Utrecht, in Utrecht, the Netherlands. The first stage determines the amount and location of arterial calcification in the coronary arteries and the aorta using DL. The second stage uses a more conventional statistical approach for mortality prediction. The second stage also indicates which features are most predictive for five-year mortality.
“The analysis shows we found predictors that are typically not described in a literature, possibly because we performed analysis in lung cancer screening participants who are already at high risk of cardiovascular disease from a history of heavy smoking and the presence of extensive arterial calcification,” Dr. de Vos said.
The method could easily be integrated into lung cancer screening, Dr. de Vos said. It does not require any special equipment and would not add time to the exam.
“The method uses only image information, it is fully automatic, and it is fast,” Dr. de Vos said. “The method obtains calcium scores in a complete chest CT in less than half a second. This means that the method should be easy to implement in routine patient work ups and screening.”
Most importantly, the method could help identify people in a population of heavy smokers who might be at increased risk of death from cardiovascular disease-related causes.
“Lung screening studies show that heavy smokers die from cardiovascular disease as much as from lung cancer,” Dr. de Vos said. “But we also see that some people with very high calcium scores survive, while others with low scores do suffer from major cardiac events. The work offers a direction for future research to precisely pinpoint which calcifications are dangerous.”
The researchers have developed a number of methods for automatic calcium scoring that can be applied to a wide variety of data. They are now working toward a calcium scoring method that accurately detects arterial calcification in low-quality data, like data affected by cardiac motion, low image resolution or high noise levels.
“We developed a method, for example, that can detect coronary calcifications even when the lesions are below the clinically used threshold,” Dr. de Vos said. “This way, we hope to increase the reproducibility of calcium scoring and enable more accurate prediction.”
The United States Preventive Services Task Force (USPSTF) recently expanded its recommendation for low-dose CT lung cancer screening to include high-risk individuals, 50 to 80 years of age, who have a 20-pack-year or more history of smoking and are either current smokers or former smokers who have quit within the last 15 years, facilitating screening access for a larger and more diverse population. Read more in RSNA News.
For More Information
Access the Radiology: Cardiothoracic Imaging study, “Deep Learning Quantified Calcium Scores for Automatic Cardiovascular Mortality Prediction in Lung Screening Low-Dose CT.”
Read previous RSNA News stories on low-dose CT for lung screening:
